2,650
Participants
Start Date
November 15, 2019
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Zoledronic Acid 5Mg/Bag 100Ml Inj
Zoledronic acid 5mg/100 ml IV infusion: Zoledronic acid-5 mg (ZA) is an FDA approved therapy for men and postmenopausal women for the treatment and prevention of osteoporosis.
Placebo
Normal Saline 100 ml (placebo) IV infusion
New York University Langone Health, New York
Mount Sinai Beth Israel, New York
Columbia University, New York
Weill Cornell Medicine, New York
Northwell Health, Great Neck
Northwell Health, Manhasset
Northwell Health, Glen Cove
Stony Brook University Medical Center, East Setauket
Stony Brook University Medical Center, Stony Brook
Albany Medical College, Albany
University of Rochester, Rochester
University of Pittsburgh, Pittsburgh
Lankenau Medical Center, Wynnewood
University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Wake Forest University, Winston-Salem
Duke University, Durham
Medical University of South Carolina, Charleston
Morehouse School of Medicine, Atlanta
Emory University School of Medicine, Atlanta
Augusta University, Augusta
Mayo Clinic, Jacksonville
University of Florida, Gainesville
Parkinson's Foundation, Miami
University of Miami, Miami
Vanderbilt University Medical Center, Nashville
Veracity Neuroscience LLC, Memphis
University of Kentucky, Lexington
The Ohio State University, Columbus
Case Western Reserve University, UH Cleveland, Cleveland
University of Cincinnati, Cincinnati
Quest Research Institute, Farmington Hills
Michigan State University, East Lansing
University of Wisconsin, Madison
Mayo Clinic, Rochester
Edward Hines, Jr. VA Hospital, Hines
Northwestern Medicine, Chicago
Cook County Health & Hospitals System, Chicago
Rush University, Chicago
University of Chicago, Chicago
Loyola University, Chicago
University of Kansas Medical Center, Kansas City
Ochsner Health System, New Orleans
University of Arkansas for Medical Sciences, Little Rock
Washington Regional Medical Center, Fayetteville
University of Texas Southwestern Medical Center, Dallas
Houston Methodist Neurological Institute, Houston
University of Texas Health Houston Medical Center, Houston
University of Texas Health Science Center at San Antonio, San Antonio
University of Colorado, Denver, Aurora
St. Mary's Medical Center, Grand Junction
Intermountain Medical Center, Murray
University of Utah, Salt Lake City
Mayo Clinic, Scottsdale
Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles, Los Angeles
Loma Linda University, Loma Linda
University of California, Riverside, Riverside
University of California, Irvine, Irvine
Parkinson's and Movement Disorder Institute, Fountain Valley
University of California, San Francisco, San Francisco
Parkinson's Disease and Movement Disorder Center of Silicon Valley, Palo Alto
Sutter Health, Berkeley
Valley Parkinson Clinic, Los Gatos
Sutter Health, Sacramento
University of California, Davis, Sacramento
Queens Medical Center, Honolulu
Oregon Health & Science University, Portland
Booth Gardner Parkinson's Care Center at EvergreenHealth, Kirkland
University of Connecticut, Farmington
University of Connecticut, Farmington
Hartford Healthcare, Hartford
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Boston University, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
University of Vermont, Burlington
Collaborators (1)
National Institute on Aging (NIA)
NIH
University of California, San Francisco
OTHER
Duke University
OTHER
University of Pittsburgh
OTHER
Parkinson's Foundation
OTHER
California Pacific Medical Center Research Institute
OTHER